This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Octapharma Ag. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Michael Andesner: Innovator in Coagulation Factor Xa Preparation
Introduction
Michael Andesner is a notable inventor based in Wien, Austria. He has made significant contributions to the field of biochemistry, particularly in the preparation of high-purity Coagulation Factor Xa (FXa). His innovative work has implications for medical applications, especially in coagulation therapies.
Latest Patents
Michael Andesner holds a patent for the "FX activation process and its use in the preparation of a FXa composition." This invention relates to a high purity Coagulation Factor Xa preparation and an activation and purification process to obtain FXa of high purity and high degree of activation without the addition of proteinaceous activators during manufacturing. He has 1 patent to his name.
Career Highlights
Michael Andesner is associated with Octapharma AG, a company known for its focus on human proteins for the treatment of various medical conditions. His work at Octapharma AG has allowed him to contribute to advancements in coagulation therapies.
Collaborations
Throughout his career, Michael has collaborated with notable colleagues, including Juergen Roland Roemisch and Katharina Pock. These collaborations have further enhanced the impact of his work in the field.
Conclusion
Michael Andesner's contributions to the preparation of Coagulation Factor Xa highlight his innovative spirit and dedication to improving medical treatments. His patent and work at Octapharma AG underscore his role as a key figure in biochemistry.